AI Portfolio Summary
In 2025 Q4, Column Group LLC maintained a portfolio of 5 distinct positions. They heavily accumulated shares in Surrozen, Inc., increasing their position by 23.4%. The fund also reduced its exposure to RAPT Therapeutics In by 5.9%.
Total Positions
5
Quarter
2025 Q4
Top Holding
N/A (50.5%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-5 of 5
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
N/A
Surrozen, Inc.
|
—
|
Unknown | 50.54% | 23.88% |
#1
1
Prev: #2
|
8.5 | 351,577 | 23.4% |
P
S
|
1,851,350 | $41,840,510 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
ORIC
ORIC Pharmaceut...
|
Healthcare | 34.98% | 52.48% |
#2
1
Prev: #1
|
6.5 | no change | no change |
P
S
|
3,540,777 | $28,963,556 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNYA
Tenaya Therapeu...
|
Healthcare | 8.08% | 18.35% |
#3
Prev: #3
|
5.2 | no change | no change |
P
S
|
9,400,290 | $6,693,006 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RAPT
RAPT Therapeuti...
|
Healthcare | 6.39% | 5.29% |
#4
Prev: #4
|
3.6 | -9,805 | -5.9% |
P
S
|
156,270 | $5,292,878 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
Revolution Medi...
|
Healthcare | 0.00% | 0.00% |
#5
Prev: #5
|
1.5 | no change | no change |
P
S
|
46 | $3,664 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-5 of 5 holdings